ClinicalTrials.gov
ClinicalTrials.gov Menu

Reversal of the Antithrombotic Action of New Oral Anticoagulants (REVANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01478282
Recruitment Status : Unknown
Verified March 2012 by Gines Escolar, Fundacion Clinic per a la Recerca Biomédica.
Recruitment status was:  Recruiting
First Posted : November 23, 2011
Last Update Posted : March 12, 2012
Sponsor:
Collaborator:
Ministry of Health, Spain
Information provided by (Responsible Party):
Gines Escolar, Fundacion Clinic per a la Recerca Biomédica

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2012
  Estimated Study Completion Date : December 2012

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 23, 2015
March 31, 2015
2 August 11, 2015
September 11, 2015